Latest H5N1 clinical trials Stories
ATLANTA, Feb. 23, 2011 /PRNewswire/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX) announced today the publication of the results of Phase 1 clinical trial testing of its HIV/AIDS vaccine products.
Nasal spray vs. injection -- what would you prefer?
ROCKVILLE, Md., Feb. 18, 2011 /PRNewswire/ -- Novavax, Inc.
QUEBEC CITY, Feb. 15 /PRNewswire-FirstCall/ - Medicago Inc. (TSX: MDG) a biotechnology company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles (VLPs), today announced that Ms.
-The Company launches the clinical development of its seasonal flu vaccine- QUEBEC CITY, Feb. 8 /PRNewswire-FirstCall/ - Medicago Inc.
The World Health Organization (WHO) is reviewing the safety of GlaxoSmithKline's Pandemrix H1N1 flu vaccine after a Finnish study suggested children who got the shot were nine times more likely to suffer from narcolepsy.
- Company's results continue to be amongst the best for influenza vaccine manufacturing technologies - -Company's VLP induced the production of antibodies that cross react with multiple strains of influenza- QUEBEC CITY, Feb. 1 /PRNewswire-FirstCall/ - Medicago Inc.
PRINCETON, N.J., Jan. 27, 2011 /PRNewswire/ -- Soligenix, Inc.
The Phase 2a clinical trial for HIV/AIDS vaccine has now expanded from 225 to 300 participants (Vocus/PRWEB) January 13, 2011 GeoVax Labs, Inc. recently announced the expansion of the Phase 2a clinical trial testing of its HIV/AIDS vaccine products.
Two doses of the chickenpox vaccine provide excellent protection in children against the highly-contagious itchy disease, according to a new study.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.